Back to Hudson Bay Capital Management LP

NBIX
Showing 8 of 23 quarters

Position history for Hudson Bay Capital Management LP's holdings in NEUROCRINE BIOSCIENCES INC

Hudson Bay Capital Management LP holds 395,850 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $52.1M as of 2026-Q1. The position was increased (+29.8% shares). NBIX represents 0.2% of Hudson Bay Capital Management LP's portfolio.

Current Value

$52.1M

Current Shares

395,850

Total Value Change

+$46M

Total Shares Change

+350,850

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
395,850
+29.8%
$52.1M0.2%$131.14
44
2025-Q4
Increased
305,000
+652.9%
$43.3M0.1%$140.95
56
2025-Q3
Decreased
40,510
-47.8%
$5.7M0.0%$140.27
0
2025-Q2
Decreased
77,593
-48.4%
$9.8M0.0%$125.42
0
2025-Q1
Increased
150,380
+395.6%
$16.6M0.1%$113.16
46
2024-Q4
Decreased
30,342
-24.1%
$4.1M0.0%$137.06
0
2024-Q3
Decreased
40,000
-11.1%
$4.6M0.0%$115.06
0
2024-Q2
Increased
45,000
+50.0%
$6.2M0.0%$137.67
38

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used